RTTNews | Dec 11, 2021 12:07PM EST

12:06 Saturday, December 11, 2021 (RTTNews) - MorphoSys Announces Additional Results From RE-MIND2 Study Of Tafasitamab - Lenalidomide For DLBCL

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved